{"database": "openregs", "table": "documents", "rows": [["FDA-2014-N-1210-3455", "FDA", "FDA-2014-N-1210", "Reference 25-Unal, A., et al., Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:00:31Z", null, 0, 0, "0900006483875e58"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-N-1210-3455"], "units": {}, "query_ms": 68.15496692433953, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}